Neurocrine Biosciences
NBIX
#1554
Rank
โ‚น988.43 B
Marketcap
โ‚น9,914
Share price
0.15%
Change (1 day)
-9.97%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): โ‚น162.41

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is โ‚น170.23. In 2022 the company made an earnings per share (EPS) of โ‚น139.83 an increase over its 2021 EPS that were of โ‚น82.51.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น162.4116.14%
2022โ‚น139.8369.47%
2021โ‚น82.51-78.21%
2020โ‚น378.67990%
2019โ‚น34.7481.82%
2018โ‚น19.11-113.5%
2017-โ‚น141.570.62%
2016-โ‚น140.7057.28%
2015-โ‚น89.4625.61%
2014-โ‚น71.2218.84%
2013-โ‚น59.93-1085.71%
2012โ‚น6.08-89.71%
2011โ‚น59.06-500%
2010-โ‚น14.76-86.92%
2009-โ‚น112.91-43.48%
2008-โ‚น199.76-57.8%
2007-โ‚น473.3492.58%
2006-โ‚น245.79371.67%
2005-โ‚น52.11-52.76%
2004-โ‚น110.3036.56%
2003-โ‚น80.77-70%
2002-โ‚น269.24118.31%
2001-โ‚น123.338.4%
2000-โ‚น113.7848.86%
1999-โ‚น76.43-20%
1998-โ‚น95.54-479.31%
1997โ‚น25.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น181.52 6.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น47.77-71.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
-โ‚น257.08-251.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น471.54 177.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น319.67 87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น161.54-5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น40.82-123.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น263.16-254.59%๐Ÿ‡บ๐Ÿ‡ธ USA